1923
|
Nordisk Insulin laboratorium founded.
|
1925
|
Novo Terapeutisk Laboratorium founded.
|
1932
|
Nordisk Insulin laboratorium founds the Steno Memorial Hospital.
|
1938
|
Novo founds Hvidøre Hospital.
|
1941
|
Novo launches its first enzyme - trypsin - extracted from the pancreas and used for the softening of leather.
|
1946
|
Nordisk develops Isophane insulin (NPH), a neutral insulin with prolonged action.
|
1947
|
Penicillin Novo - Novo's first product to be manufactured through fermentation.
|
1953
|
Lente® - a long-acting insulin-zinc suspension.
|
1963
|
Alcalase® - Novo's first detergent enzyme produced by fermentation.
|
1973
|
Nordisk Gentofte markets human growth hormone for the treatment of growth hormone insufficiency. The growth hormone is extracted from human pituitary glands.
|
1973
|
Monocomponent (MC) insulin is introduced - the purest insulin available.
|
1974
|
Novo's B shares are quoted on the Copenhagen Stock Exchange.
|
1979
|
An enzyme factory is built in the USin Franklinton , North Carolina.
|
1981
|
Novo becomes the first company in Scandinavia to be quoted on the New York Stock Exchange.
|
1982
|
Human Monocomponent insulin - the world's first insulin preparation identical to human insulin. It is extracted from the pancreas of pigs and converted to human insulin.
|
1985
|
NovoPen® - an injection system similar in appearance to a fountain pen, with replaceable insulin cartridges.
|
1987
|
Novo starts production of human insulin with the help of genetically engineered yeast cells.
|
1988
|
Nordisk Gentofte markets genetically engineered human growth hormone.
|
1988
|
Novo launches Lipolase®, the world's first fat-splitting enzymefor detergents. It is also the first enzyme to be produced on the basis of genetically engineered microorganisms.
|
1989
|
Novo Industri A/S and Nordisk Gentofte A/S merge to become the world's leading producer of insulin.
|
1989
|
NovoLet® is marketed - the world's first prefilled insulin syringe.
|
1991
|
Durazym® - a detergent enzyme developed through protein engineering.
|
1992
|
Seroxat® is launched - a drug for the treatment of depression.
|
1992
|
The Steno Memorial and Hvidoere Hospitalsmerge to form the Steno Diabetes Center.
|
1993
|
The Kalundborg factory gets its own biological treatment plant.
|
1994
|
Novo Nordisk is the first company in Denmark- and one of the first in the world - to publish an environmental report.
|
1995
|
Novo Nordisk enters into a joint venture agreement with the Chinese enzyme producer Suzhou Hongda Group, and at the same time commences the construction of its own enzyme manufacturing plant in China.
|
1996
|
NovoSeven® for the treatment of haemophilia patients with inhibitor reaction is launched.
|
1997
|
Novo Nordisk launches Norditropin® human growth hormone in the US.
|
1998
|
NovoNorm®, (PrandinTM in the US) - Novo Nordisk's new oral treatment for Type 2 diabetes - is launched in the USand Europe .
|
|
Novo Nordisk's enzyme production plant in Tianjin , Chinabecomes operational.
|
|
Novo Nordisk and Aradigm sign worldwide agreement to develop a pulmonary insulin delivery system.
|
1999
|
Novo Nordisk launches Kliovance® in Australia
|
2000
|
Novo Nordisk and NovoZymes demerge into two separate companies – Novo Nordisk becoming a focused health care company
Novo Nordisk launches NovoRapid® and NovoPen® 3 Demi in Australia
|
2001
|
Launch of Norditropin® SimpleXx® and InnoLet®
|
2002
|
Novo Nordisk launches NovoMix® 30 in Australia
|
2005
|
Novo Nordisk launches Levemir® in Australia
|
2005
|
Novo Nordisk launches Norditropin® NordiFlex® in Australia
|
2009
|
Novo Nordisk launches Next Generation FlexPen® in Australia
|
2010
|
Novo Nordisk launches NovoPen® 4 in Australia
|
|
|
|
Novo Nordisk Australasia
Contact us
Sitemap
